IM Cannabis Corp. Secures $1.31 Million in Direct Offering of Shares

IM Cannabis Corp. Successfully Completes $1.31 Million Share Offering

On September 24, 2026, IM Cannabis Corp. (often referred to as IMCC), a prominent player in the medical cannabis sector with operations in Israel and Germany, announced the successful closing of a registered direct offering. This initiative saw the company selling 655,000 common shares at a price of $2.00 per share, resulting in total gross proceeds amounting to $1.31 million before expenses are deducted.

The funds garnered through this offering are earmarked for various purposes, including working capital and general corporate activities. This could potentially involve the exploration of new business opportunities that align with the company's strategic objectives.

Details of the Offering

The transaction is grounded in IMCC's effective shelf registration statement (File No. 333-288346), which received approval from the Securities and Exchange Commission (SEC) on July 9, 2025. The common shares in the offering were sold through a prospectus supplement, ensuring compliance with regulatory standards. Investors considering participation were directed towards these official documents which enhance transparency during the investment process.

It’s crucial to note that this press release does not constitute an offer to purchase or sell any specified securities, nor does it represent a solicitation in any jurisdiction where such activities are unlawful prior to necessary registrations or qualifications under securities law.

Related Party Transactions

A notable aspect of this offering includes a transaction involving a related party. Invest-Pro – Shukai Hon Ltd., associated with Eli Zamir, an IMCC director, acquired 164,585 common shares at the same price of $2.00 each. This transaction met the criteria for a